Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yerbol
    Junior Member
    • Feb 2012
    • 7

    #1

    [DEXSeq] exon counts to "PSI" (exon inclusion level)

    Hello all,

    I`m using DEXSeq to find differential splicing. It operates with raw counts of reads aligned to the exonic segments. But frequently it is worth to have inclusion levels ("PSI") assigned to exons, which is proportion of transcripts including given exonic segment among all transcripts of given gene.

    Calculation of absolute expression level of exon is seems to be not very difficult (something like FPKM): exon count * size factor (or divided to the size of library) / length of exon.

    But for inclusion level we need to find ratio of expression level of exon (FPKM/counts normalized to length) to the expression level of whole gene:
    something like "PSI" = "exonFpkm"/"geneFpkm".

    Is there any smart way to calculate something like PSI from exon count objects used in DEXSeq?

    Thank you.
  • DerSeb
    Member
    • Oct 2009
    • 44

    #2
    Hi yerbol,

    we have done just that:

    http://onlinelibrary.wiley.com/doi/1...16s87/abstract

    There is also a script available that will calculate the PSI scores as explained in the protocol for you. You can either use count files or read files as input.

    All the best,
    Sebastian

    Comment

    • Neuromancer
      Member
      • Aug 2011
      • 28

      #3
      Hi Sebastian, any chance you could provide fulltext to the article you linked? Can't get it though my university....

      Thanks,

      Roman

      Comment

      • DerSeb
        Member
        • Oct 2009
        • 44

        #4
        Dear Roman,

        feel free to contact me at:

        sebastian.schaefer and at the domain nhcs.com.sg

        Thanks for your interest in our work,
        Sebastian

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 10:35 AM
        0 responses
        4 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        41 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        47 views
        0 reactions
        Last Post SEQadmin2  
        Working...